Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2021 - 2026)

Thermo Fisher Scientific has disclosed Income from Non-Controlling Interests across 6 years of filings, most recently posting $5.0 million for Q1 2026.

• Quarterly Income from Non-Controlling Interests rose 25.0% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.0 million (up 350.0% YoY) and the FY2025 annual result came in at $17.0 million, up 466.67% from the prior year.
• Income from Non-Controlling Interests declined to $5.0 million in Q1 2026, from $6.0 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $6.0 million in Q2 2024 and troughed at -$24.0 million in Q4 2023.
• A 5-year average of -$250000.0 and a median of $3.5 million in 2022 frame the typical range for Income from Non-Controlling Interests.
• Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests tumbled 1100.0% — and 2024, when it soared 500.0%.
• Tracing TMO's Income from Non-Controlling Interests over 5 years: stood at -$2.0 million in 2022, then slumped by 1100.0% to -$24.0 million in 2023, then soared by 75.0% to -$6.0 million in 2024, then jumped by 200.0% to $6.0 million in 2025, then decreased by 16.67% to $5.0 million in 2026.
• Business Quant data shows TMO's Income from Non-Controlling Interests at $5.0 million in Q1 2026, $6.0 million in Q4 2025, and $5.0 million in Q3 2025.